A novel Trojan-horse targeting strategy to reduce the non-specific uptake of nanocarriers by non-cancerous cells

Article

Abstract: One big challenge with active targeting of nanocarriers is non-specific binding between targeting mo

Palabras claves:

Active targetability to cancer cells, MRI contrast agents, Non-specific uptake by non-cancerous cells, Trojan-horse targeting strategy

Autores:

Li Z., Ma X., Mingqian Tan, Shen Z., Wu A., Wu H., Yang S.

Fuentes:

scopus